These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro and in vivo evaluation of a factor VIII concentrate heat-treated to inactivate HTLV-III/LAV viruses. Favourable effects of heating on the von Willebrand factor. Mazurier C, de Romeuf C, Parquet-Gernez A, Jorieux S, Goudemand M. Vox Sang; 1987; 52(4):265-71. PubMed ID: 3114955 [Abstract] [Full Text] [Related]
4. Effect of virucidal heat treatment on proteins in human factor VIII concentrates. Thomas KB, McGrath KM, Taylor M, Young IF, Herrington RW, Schiff P. Transfusion; 1988; 28(1):8-13. PubMed ID: 3124306 [Abstract] [Full Text] [Related]
5. In vitro characterization of various factor VIII concentrates. Yoshioka A, Shima M, Nishino M, Yoshikawa N, Fukui H. Arzneimittelforschung; 1987 Jul; 37(7):753-6. PubMed ID: 3118888 [Abstract] [Full Text] [Related]
6. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates. Budde U, Drewke E. Beitr Infusionsther Transfusionsmed; 1994 Jul; 32():408-14. PubMed ID: 9422121 [Abstract] [Full Text] [Related]
11. Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays. Hornsey VS, Waterston YG, Prowse CV. J Clin Pathol; 1988 May; 41(5):562-7. PubMed ID: 3133400 [Abstract] [Full Text] [Related]
12. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease. Escolar G, Carretero M, Magallón M, Quintana M, Arnau C, Castillo R, Aznar-Salatti J. Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923 [Abstract] [Full Text] [Related]
13. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study. Favaloro EJ, Lloyd J, Rowell J, Baker R, Rickard K, Kershaw G, Street A, Scarff K, Barrese G, Maher D, McLachlan AJ. Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293 [Abstract] [Full Text] [Related]
19. Biochemical and in vivo properties of commercial virus-inactivated factor VIII concentrates. Berntorp E, Nilsson IM. Eur J Haematol; 1988 Mar 15; 40(3):205-14. PubMed ID: 3128452 [Abstract] [Full Text] [Related]
20. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I. Blood Coagul Fibrinolysis; 2006 Jan 15; 17(1):39-45. PubMed ID: 16607078 [Abstract] [Full Text] [Related] Page: [Next] [New Search]